Overview
Martin Lauritzen practices in Copenhagen, Denmark. Mr. Lauritzen is rated as an Advanced expert by MediFind in the treatment of Vasoconstriction. His top areas of expertise are Familial Hemiplegic Migraine, Migraine with Brainstem Aura, Vasoconstriction, and Sporadic Hemiplegic Migraine.
His clinical research consists of co-authoring 95 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Vasoconstriction.
Locations
Glostrup, 2600, Denmark
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Hemiplegic MigraineMr. Lauritzen isAdvanced. Learn about Familial Hemiplegic Migraine.
- Migraine with Brainstem AuraMr. Lauritzen isAdvanced. Learn about Migraine with Brainstem Aura.
- Sporadic Hemiplegic MigraineMr. Lauritzen isAdvanced. Learn about Sporadic Hemiplegic Migraine.
- VasoconstrictionMr. Lauritzen isAdvanced. Learn about Vasoconstriction.
- Experienced
- ADULT SyndromeMr. Lauritzen isExperienced. Learn about ADULT Syndrome.
- Alzheimer's DiseaseMr. Lauritzen isExperienced. Learn about Alzheimer's Disease.
- DeliriumMr. Lauritzen isExperienced. Learn about Delirium.
- DementiaMr. Lauritzen isExperienced. Learn about Dementia.
- Dry MouthMr. Lauritzen isExperienced. Learn about Dry Mouth.
- MigraineMr. Lauritzen isExperienced. Learn about Migraine.